Lichen International (LICN) Common Equity (2021 - 2025)

Lichen International (LICN) has 5 years of Common Equity data on file, last reported at $70.6 million in Q4 2025.

• Common Equity for Q4 2025 came in at $70.6 million, down 6.64% year-over-year; the trailing twelve-month figure through Dec 2025 was $70.6 million (down 6.64% YoY), and the FY2025 annual result was $70.6 million, down 6.64% from the prior year.
• Common Equity grew to $70.6 million in Q4 2025 per LICN's latest filing, from $64.3 million in the prior quarter.
• Over five years, Common Equity peaked at $75.6 million in Q4 2024 and troughed at $36.8 million in Q4 2021.
• A 5-year average of $58.3 million and a median of $62.8 million in 2023 frame the typical range for Common Equity.
• The sharpest annual moves came in 2023 and 2025: Common Equity surged 49.41% in 2023, then slipped 6.64% in 2025.
• A 5-year view of Common Equity shows it stood at $36.8 million in 2021, then rose by 11.61% to $41.1 million in 2022, then soared by 49.41% to $61.4 million in 2023, then rose by 23.03% to $75.6 million in 2024, then retreated by 6.64% to $70.6 million in 2025.
• Business Quant data shows LICN's Common Equity at $70.6 million in Q4 2025, $64.3 million in Q2 2025, and $75.6 million in Q4 2024.